APA (7th ed.) Citation

Badran, A. S., & Gbreel, M. I. (2025). From diabetes to dopamine: Evaluating the disease-modifying potential of GLP-1 receptor agonists in Parkinson's disease. A systematic review and meta-analysis of placebo-controlled trials. Neurological Sciences, 46(11), 5643. https://doi.org/10.1007/s10072-025-08411-4

Chicago Style (17th ed.) Citation

Badran, Ahmed Samy, and Mohamed Ibrahim Gbreel. "From Diabetes to Dopamine: Evaluating the Disease-modifying Potential of GLP-1 Receptor Agonists in Parkinson's Disease. A Systematic Review and Meta-analysis of Placebo-controlled Trials." Neurological Sciences 46, no. 11 (2025): 5643. https://doi.org/10.1007/s10072-025-08411-4.

MLA (9th ed.) Citation

Badran, Ahmed Samy, and Mohamed Ibrahim Gbreel. "From Diabetes to Dopamine: Evaluating the Disease-modifying Potential of GLP-1 Receptor Agonists in Parkinson's Disease. A Systematic Review and Meta-analysis of Placebo-controlled Trials." Neurological Sciences, vol. 46, no. 11, 2025, p. 5643, https://doi.org/10.1007/s10072-025-08411-4.